Spots Global Cancer Trial Database for nk cell infusion
Every month we try and update this database with for nk cell infusion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | NCT01875601 | Solid Tumors Brain Tumors Sarcoma Pediatric Cance... Neuroblastoma | Recombinant hum... NK Cell Infusio... | 2 Years - 29 Years | National Institutes of Health Clinical Center (CC) | |
NK Cells Infusion for Advanced Malignancies | NCT03619954 | Immunotherapy | NK cells infusi... | 18 Years - 75 Years | Anhui Provincial Hospital | |
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia | NCT01478074 | Acute Myeloid L... | G-CSF Cytarabine Fludarabine Donor Natural K... ALT-801 | 2 Years - 59 Years | Altor BioScience | |
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma | NCT00698009 | Neuroblastoma | Fludarabine Cyclophosphamid... Natural Killer ... Mesna Interleukin-2 | - | M.D. Anderson Cancer Center | |
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies | NCT00697671 | Acute Lymphobla... Chronic Myeloge... Juvenile Myelom... Myelodysplastic... Non-Hodgkin's L... | NK Cell Infusio... Immunotherapy Miltenyi Biotec... Interleukin-2 (... Clofarabine Cyclophosphamid... Etoposide | - 18 Years | St. Jude Children's Research Hospital | |
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents | NCT02763475 | Acute Myeloid L... Leukemia Myeloid Leukemi... | cyclophosphamid... Fludarabine NK cell infusio... IL-2 | - 21 Years | Instituto de Investigación Hospital Universitario La Paz | |
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation | NCT00383994 | Lymphoma Leukemia Transplantation... Lymphoid Malign... Disorder Relate... | GM-CSF Rituximab NK Cell Infusio... | - | M.D. Anderson Cancer Center | |
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia | NCT00995137 | Lymphoblastic L... | NK Cell Infusio... | - 18 Years | St. Jude Children's Research Hospital | |
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | NCT01875601 | Solid Tumors Brain Tumors Sarcoma Pediatric Cance... Neuroblastoma | Recombinant hum... NK Cell Infusio... | 2 Years - 29 Years | National Institutes of Health Clinical Center (CC) | |
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | NCT01875601 | Solid Tumors Brain Tumors Sarcoma Pediatric Cance... Neuroblastoma | Recombinant hum... NK Cell Infusio... | 2 Years - 29 Years | National Institutes of Health Clinical Center (CC) |